M 
McKesson MCK · USD
Health Care · Health Care Providers & Services · US listing · 🇺🇸 United States
S&P 500
1,059.37
-0.14%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in USD, from our data supplier.
Revenue
$403.43bn
FY2017FY2026
Net income
$4.76bn
FY2017FY2026
Free cash flow
$5.72bn
FY2017FY2026
Shareholders' equity
−$2.17bn
FY2017FY2026
Income statement
Fiscal years
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $403.43bn | $359.05bn | $308.95bn | $276.71bn | $263.97bn | $238.23bn | $231.05bn | $214.32bn | $208.36bn | $198.53bn |
| Gross profit | $14.55bn | $12.48bn | $12.20bn | $11.87bn | $12.65bn | $11.58bn | $11.40bn | $10.76bn | $10.39bn | $10.69bn |
| Research and development | $103.0m | $91.0m | $77.0m | $89.0m | $70.0m | $74.0m | $96.0m | $71.0m | $125.0m | $341.0m |
| Operating income | $6.45bn | $4.37bn | $3.93bn | $4.88bn | $2.72bn | $3.51bn | $3.01bn | $874.0m | $2.92bn | $7.20bn |
| Net income | $4.76bn | $3.29bn | $3.00bn | $3.56bn | $1.11bn | −$4.54bn | $900.0m | $34.0m | $67.0m | $5.18bn |
| Diluted earnings per share | 39.95 | 26.64 | 23.71 | 26.71 | 7.90 | -29.94 | 5.64 | 0.19 | 0.34 | 24.92 |
Balance sheet
At each fiscal year end
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $82.32bn | $75.14bn | $67.44bn | $62.32bn | $63.30bn | $65.02bn | $61.25bn | $59.67bn | $60.38bn | $60.97bn |
| Cash and short-term investments | $3.98bn | $5.69bn | $4.58bn | $4.68bn | $3.53bn | $6.28bn | $4.01bn | $2.98bn | $2.67bn | $2.78bn |
| Total liabilities | $83.16bn | $76.83bn | $69.04bn | $63.81bn | $65.09bn | $63.57bn | $54.54bn | $49.99bn | $48.87bn | $48.37bn |
| Debt | $6.81bn | $5.65bn | $5.63bn | $5.59bn | $5.88bn | $7.15bn | $7.39bn | $7.59bn | $7.88bn | $8.54bn |
| Shareholders' equity | −$2.17bn | −$1.69bn | −$1.60bn | −$1.49bn | −$1.79bn | $1.45bn | $6.71bn | $9.68bn | $11.52bn | $12.60bn |
| Shares outstanding | 119m | 124m | 127m | 133m | 141m | 152m | 160m | 180m | 195m | 208m |
Cash flow
Fiscal years
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | $6.16bn | $6.08bn | $4.31bn | $5.16bn | $4.43bn | $4.54bn | $4.37bn | $4.04bn | $4.34bn | $4.74bn |
| Capital spending | −$436.0m | −$859.0m | −$687.0m | −$558.0m | −$535.0m | −$641.0m | −$506.0m | −$557.0m | −$580.0m | −$562.0m |
| Free cash flow | $5.72bn | $5.23bn | $3.63bn | $4.60bn | $3.90bn | $3.90bn | $3.87bn | $3.48bn | $3.77bn | $4.18bn |
| Dividends paid | −$381.0m | −$345.0m | −$314.0m | −$292.0m | −$277.0m | −$276.0m | −$294.0m | −$292.0m | −$262.0m | −$253.0m |
Latest quarters
By quarter end
| Jun 2026 | Mar 2026 | Dec 2025 | Sept 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sept 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $105.38bn | $96.30bn | $106.16bn | $103.15bn | $97.83bn | $90.82bn | $95.29bn | $93.65bn |
| Gross profit | $3.69bn | $4.04bn | $3.69bn | $3.54bn | $3.28bn | $2.92bn | $3.22bn | $3.15bn |
| Operating income | $1.32bn | $2.25bn | $1.66bn | $1.47bn | $1.10bn | $1.04bn | $1.29bn | $745.0m |
| Net income | $614.0m | $1.68bn | $1.19bn | $1.11bn | $784.0m | $1.26bn | $879.0m | $241.0m |
| Diluted earnings per share | 5.15 | 14.11 | 9.59 | 8.97 | 6.34 | 10.19 | 6.94 | 1.90 |
| Cash from operations | −$220.0m | $3.42bn | $1.23bn | $2.42bn | −$918.0m | $7.75bn | −$2.38bn | $2.10bn |
| Capital spending | −$112.0m | −$111.0m | −$108.0m | −$111.0m | −$111.0m | −$278.0m | −$196.0m | −$218.0m |
| Free cash flow | −$332.0m | $3.31bn | $1.12bn | $2.31bn | −$1.03bn | $7.47bn | −$2.58bn | $1.88bn |
| Total assets | $88.33bn | $82.32bn | $84.19bn | $84.16bn | $81.31bn | $75.14bn | $71.08bn | $72.43bn |
| Cash and short-term investments | $5.16bn | $3.98bn | $2.96bn | $4.11bn | $2.42bn | $5.69bn | $1.13bn | $2.51bn |
| Debt | $10.02bn | $6.81bn | $8.62bn | $9.79bn | $9.93bn | $7.39bn | $9.76bn | $5.99bn |
| Shareholders' equity | −$4.24bn | −$2.17bn | −$99.0m | −$578.0m | −$863.0m | −$1.69bn | −$2.70bn | −$2.64bn |
Financial ratios
Data as of 8 Sept 2026
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Gross margin | 3.6% | 3.5% | 3.9% | 4.3% | 4.8% | 4.9% |
| Operating margin | 1.6% | 1.2% | 1.3% | 1.8% | 1.0% | 1.5% |
| Net margin | 1.2% | 0.9% | 1.0% | 1.3% | 0.4% | -1.9% |
| Return on equity | -219.2% | -194.5% | -187.7% | -238.9% | -62.2% | -313.9% |
| Return on assets | 5.8% | 4.4% | 4.5% | 5.7% | 1.8% | -7.0% |
| Free cash flow yield | 6.4% | 6.2% | 4.4% | 4.7% | 3.9% | 3.8% |
| Revenue growth | 12.4% | 16.2% | 11.7% | 4.8% | 10.8% | 3.1% |
| Earnings growth | 44.5% | 9.8% | -15.7% | 219.6% | -124.5% | -604.3% |
| Current ratio | 0.85x | 0.90x | 0.92x | 0.92x | 0.95x | 1.03x |
| Debt to equity | -3.14x | -3.49x | -3.70x | -3.96x | -3.45x | 5.21x |
| Equity ratio | -2.6% | -2.3% | -2.4% | -2.4% | -2.8% | 2.2% |
| Interest coverage | 26.13x | 17.08x | 16.16x | 19.67x | 15.30x | 16.18x |
| R&D as a share of sales | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Buybacks as a share of market value | 3.6% | 2.3% | 5.0% | 5.5% | 7.0% | 5.0% |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | 13.4% | 11.1% | 7.8% |
| Operating income | 9.8% | 13.0% | 5.3% |
| Net income | 10.2% | — | 7.7% |
Average margins
Over each period
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Gross margin | 3.5% | 3.8% | 4.1% | 4.5% |
| Operating margin | 1.4% | 1.5% | 1.4% | 1.5% |
| Net margin | 1.1% | 1.1% | 0.6% | 0.7% |
Valuation history
At each fiscal year end
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings | 26.8 | 30.8 | 24.0 | 17.3 | 47.5 | -8.3 | 30.8 | — | 321.5 | 6.3 |
| Price to sales | 0.3 | 0.3 | 0.2 | 0.2 | 0.2 | 0.2 | 0.1 | 0.1 | 0.1 | 0.2 |
Market value over time
31 Oct 2016 to 4 Sept 2026, in USD
$28.99bn$108.23bn
Share price return
Finished calendar years
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Return | 42% | 27% | 19% | 60% | 37% | 25% | 25% | -32% | 14% | -28% |
Dividends and splits
Per share, in the currency the company pays
Paid for 32 years. Last went ex-dividend on 1 Sept 2026.
| FY2027 | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | |
|---|---|---|---|---|---|---|---|---|
| Paid in the year | 1.76 | 3.17 | 2.75 | 2.40 | 2.09 | 2.25 | 1.67 | 1.62 |
- 1-to-1 reverse split · 10 Mar 2020
- 2-for-1 split · 5 Jan 1998
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.